Spectrum Pharma Inc (SPPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 122,271 | 276,652 | 157,480 | 166,541 | 174,371 |
| Marketable Securities | 160,134 | 33,229 | 46,508 | 54,014 | 95,287 |
| Receivables | 12,771 | 22,402 | 33,571 | 34,616 | 30,573 |
| Inventories | N/A | N/A | N/A | 3,979 | 4,520 |
| Other current assets | 0 | 0 | 5,555 | 0 | 0 |
| TOTAL | $306,015 | $340,238 | $250,688 | $267,450 | $309,520 |
| Non-Current Assets | |||||
| PPE Net | 4,534 | 466 | 385 | 437 | 523 |
| Intangibles | 0 | 0 | 0 | 134,364 | 141,320 |
| Other Non-Current Assets | 12,119 | 11,954 | 139,813 | 10,376 | 13,159 |
| TOTAL | $16,653 | $12,420 | $140,198 | $145,177 | $155,002 |
| Total Assets | $322,668 | $352,658 | $390,886 | $412,627 | $464,522 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 44,455 | 60,302 | 81,312 | 57,633 | 49,886 |
| Accrued Expenses | 5,262 | 5,168 | 9,853 | 7,744 | 4,946 |
| Other current liabilities | 7,245 | 4,850 | 7,161 | 211 | 211 |
| TOTAL | $56,962 | $70,320 | $98,326 | $100,945 | $94,470 |
| Non-Current Liabilities | |||||
| Long Term Debt | 10,923 | N/A | N/A | N/A | N/A |
| Deferred Revenues | N/A | N/A | N/A | N/A | 39,427 |
| Other Non-Current Liabilities | 0 | 9,789 | 19,681 | 23,457 | 24,486 |
| TOTAL | $10,923 | $9,789 | $21,150 | $24,904 | $25,933 |
| Total Liabilities | $67,885 | $80,109 | $119,476 | $125,849 | $120,403 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 112,856 | 111,964 | 111,050 | 106,913 | 105,959 |
| Common Shares | 112 | 111 | 110 | 106 | 103 |
| Retained earnings | -647,436 | -619,041 | -611,738 | -550,667 | -481,948 |
| Other shareholders' equity | -3,764 | -4,092 | -3,702 | -3,342 | -3,088 |
| TOTAL | $254,783 | $272,549 | $271,410 | $286,778 | $344,119 |
| Total Liabilities And Equity | $322,668 | $352,658 | $390,886 | $412,627 | $464,522 |